# Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer

> **NCT02370277** · — · COMPLETED · sponsor: **University of Southern California** · enrollment: 36 (actual)

## Conditions studied

- Ductal Breast Carcinoma In Situ
- Invasive Breast Carcinoma
- Stage I Breast Cancer
- Stage IIA Breast Cancer
- Stage IIB Breast Cancer
- Stage IIIA Breast Cancer

## Interventions

- **OTHER:** Cytology Specimen Collection Procedure
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT02370277
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-16
- **Primary completion:** 2016-06-15
- **Final completion:** 2018-08-22
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370277, "Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02370277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*